This is the story that YOU wanted to hear us talk about! It received 56 percent of the vote in our Radioactive poll!
The on-going Ebola health crisis is capturing world headlines, but it could lead to one company capturing quite a hefty profit.
According to USA Today, shares of Tekmira Pharmaceuticals jumped 45 percent Friday after the Food and Drug Administration moved an Ebola treatment one step closer to approval.
“We are pleased that the FDA has considered the risk-reward of TKM-Ebola for infected patients. We have been closely watching the Ebola virus outbreak and its consequences, and we are willing to assist with any responsible use of TKM-Ebola. The foresight shown by the FDA removes one potential roadblock to doing so,” said Dr. Mark Murray, CEO of Tekmira Pharmaceuticals.
The drug may work, but we think it feels wrong that a company can make a fortune off of helping sick people.
What do you think?
- Garcia: ‘Real’ plan would erase education deficit, raise teacher’s pay
- Arizona DCS head responds to claims of failed foster care protections
- Ducey responds to Don Shooter’s claims of ‘suspicious’ state contracts
- McSally defends sharp language used in U.S. Senate announcement
- Sheriff Paul Penzone looking to eliminate ‘Tent City’ phrase in 2018